Jie Chao | DNA Nanotechnology | Best Researcher Award

Prof. Jie Chao | DNA Nanotechnology | Best Researcher Award 

Prof. Jie Chao is a leading researcher in DNA nanotechnology and biomedical diagnostics. She earned her PhD from Nanjing University and currently serves as the Director of the National Key Laboratory of Biological Intelligent Materials and Diagnosis & Treatment Technologies and Dean of Portland College at Nanjing University of Posts and Telecommunications. She has pioneered intelligent DNA nanodevices for precise disease diagnosis and targeted therapy, introducing novel concepts such as “pattern recognition” molecular sensing and “logical decision-making” diagnostics. With 149 SCI publications and multiple national research projects, she is a recipient of the National Excellent Young Scientist Fund and Jiangsu Province Outstanding Youth Fund.

Prof. Jie Chao | Nanjing University of Posts and Telecommunications | China

Profile

SCOPUS ID

🎓Education

  • Prof. Jie Chao received her PhD degree from Nanjing University, where she developed a strong foundation in nanotechnology, molecular diagnostics, and biomedical engineering. Her academic journey has been marked by a dedication to advancing DNA nanodevices and their applications in precision medicine.

👨‍🏫Experience

  • Currently serving as a Professor at Nanjing University of Posts and Telecommunications, Prof. Jie Chao holds several key leadership positions. She is the Director of the National Key Laboratory of Biological Intelligent Materials and Diagnosis & Treatment Technologies (Fostering Construction Site) and the Dean of the Portland College at Nanjing University of Posts and Telecommunications. With extensive experience in research and innovation, she has pioneered the concepts of “pattern recognition” molecular sensing and “logical decision-making” intelligent diagnosis and therapy, contributing significantly to the field of biomedical engineering.

🏆Awards and Recognitions

  • Prof. Chao has been recognized for her outstanding contributions to science and technology. She is a recipient of the National Excellent Young Scientist Fund and the Jiangsu Province Outstanding Youth Fund. Her groundbreaking research has been extensively featured in prestigious international journals, underscoring her impact on the scientific community.

💡Skills and Certifications

  • Her expertise lies in DNA nanotechnology, chemical and biological sensing, molecular diagnostics, targeted therapy, and intelligent biomedical devices. She specializes in designing and assembling programmable DNA nanodevices with precise structures and functions, enabling advanced applications in disease detection and treatment. Her work integrates molecular self-adaptation and self-driving mechanisms, pushing the boundaries of intelligent medical diagnostics.

🔬 Research Focus

  • Prof. Chao’s research is centered on developing innovative in vitro diagnostic techniques and targeted therapeutic strategies for major diseases. She has made significant advancements in constructing dynamic DNA nanodevices with hierarchical assembly methods, enabling deep molecular search and parallel computation at the single-molecule level. Her pioneering strategies in pattern recognition and intelligent decision-making in DNA nanodevices have led to a deeper understanding of biological recognition mechanisms, opening new possibilities for precise medical diagnostics and treatment. Her groundbreaking studies have been published in top-tier journals such as Nature Materials, Nature Chemistry, Science Advances, Journal of the American Chemical Society, Angewandte Chemie International Edition, and ACS Nano, cementing her position as a leader in the field of DNA nanotechnology.

🌎Conclusion

  • Prof. Jie Chao is an exemplary scientist whose research has significantly advanced DNA nanotechnology, biomedical diagnostics, and intelligent disease therapy. Her ability to combine interdisciplinary knowledge with innovative methodologies has led to groundbreaking discoveries with global impact. With an outstanding track record in research, innovation, leadership, and academic contributions, she is a highly deserving candidate for the Best Researcher Award. Her pioneering work not only contributes to the advancement of scientific knowledge but also has profound implications for improving medical diagnostics and treatment worldwide

📖Publications

  • Artificial molecular communication network based on DNA nanostructures recognition
    Authors: J. Wang, M. Xie, L. Ouyang, C. Fan, J. Chao
    Journal: Nature Communications, 2025

  •  Parameter Pool-Assisted Centrifugation Sorter for Multiscale Higher-Order DNA Nanomaterials
    Authors: L. Ouyang, J. Wang, B. Liu, C. Fan, J. Chao
    Journal: ACS Nano, 2025

  • The enhancing effect of DNA tetrahedron-based lactoferrin as an assembled adjuvant in immunotherapy
    Authors: M. Xu, T. Zhou, B. Yang, D. Zhu, L. Weng
    Journal: Chemical Engineering Journal, 2025

  •  Non-discriminating engineered masking of immuno-evasive ligands on tumour-derived extracellular vesicles enhances tumour vaccination outcomes
    Authors: X. Ding, J. Zhang, S. Wan, D.T. Leong, L. Wang
    Journal: Nature Nanotechnology, 2025

  • Non-enzymatic aptazyme-driven autonomous DNA circuits coupled with three-junction CHA for amplified live-cell ATP imaging
    Authors: D. Zhu, Y. Hu, Y. Xia, S. Su, L. Wang
    Journal: Sensors and Actuators B: Chemical, 2024

Bilal Murtaza | Bioengineering | Young Scientist Award

Dr. Bilal Murtaza | Bioengineering | Best Researcher Award

Dr. Bilal Murtaza, Dalian University of Technology, China

Profile

Scopus

OrcID

📚 Early Academic Pursuits

Bilal Murtaza began his academic journey with a strong foundation in veterinary sciences. He earned his Doctor of Veterinary Medicine (DVM) degree from the University of Agriculture, Faisalabad, Pakistan, in 2014, graduating with first division honors. Driven by a passion for pathology, he pursued an M.Phil. in Pathology at the same university, which he completed in 2016 under the supervision of Prof. Dr. Muhammad Tariq Javed, achieving a commendable CGPA of 3.53/4. His academic pursuits were marked by a keen interest in the mechanisms of disease development and the development of therapeutic agents, setting the stage for his future research.

💼 Professional Endeavors

Following his M.Phil., Bilal Murtaza embarked on a Ph.D. program at the College of Bioengineering, Dalian University of Technology, China, under the supervision of Prof. Xu Yongping. His Ph.D. research, supported by the International (Regional) Cooperation and Exchange Program of the National Natural Science Foundation of China, focused on the biodegradation of mycotoxins, particularly zearalenone and deoxynivalenol, by plant rhizobacteria and probiotic strains. Throughout his academic and professional journey, Bilal developed a robust technical expertise in quantifying mycotoxins using advanced techniques such as ELISA, HPLC, and LC MS/MS, as well as in the identification and utilization of plant rhizobacteria for mycotoxin degradation.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS

  • Bilal Murtaza has made significant contributions to the field of veterinary and bioengineering sciences. His research is centered around the biodegradation of harmful mycotoxins, the development of new therapeutic agents for cancer and infectious diseases, and the use of probiotic bacteria and yeast to control mycotoxins. His work also extends to the study of viral diseases, including the isolation and cultivation of viruses, as well as the development of vaccines and the evaluation of vaccine-induced immune responses. His technical skills encompass a wide range of methodologies, from cell culture techniques and viral disease diagnosis to the isolation and identification of probiotic strains and the testing of their protective effects against infections.

🌟Impact and Influence

  • Bilal’s research has not only contributed to the scientific understanding of mycotoxins and their degradation but also holds practical implications for the development of safer food and feed products. His work on therapeutic agents for cancer and infectious diseases has the potential to influence clinical practices and lead to the development of new treatments. His expertise in histopathology, viral disease diagnosis, and the use of probiotics in disease control has made him a valuable contributor to multiple research projects.

📖 ACADEMIC CITES

Bilal Murtaza has more than seven peer-reviewed publications in well-reputed journals, reflecting the quality and impact of his research. Additionally, he has four research articles currently under consideration for publication. His scholarly contributions have been recognized by his peers, and he is an active member of several professional affiliations, including the World Veterinary Poultry Association (WVPA), the American Society for Microbiology (ASM), and the International Society for Mycotoxicology (ISM).

🌍 LEGACY AND FUTURE CONTRIBUTIONS

As Bilal Murtaza looks to the future, his ambition is to continue his work as a researcher and educator at a university or scientific institution that aligns with his personal, scientific, and professional goals. He is passionate about translational research, particularly in the fields of basic and clinical medicine, and aims to make further contributions to the development of new therapeutic agents and the understanding of disease mechanisms. His strong writing and expression skills, combined with his extensive technical expertise, position him as a future leader in his field, with a legacy that will influence both academic and practical applications in veterinary and bioengineering sciences.

📰PUBLICATIONS

  • A novel Saclayvirus Acinetobacter baumannii phage genomic analysis and effectiveness in preventing pneumonia
    • Authors: Li, S., Wei, B., Xu, L., Yin, J., Xu, Y.
    • Journal: Applied Microbiology and Biotechnology
  • Characterization of two virulent Salmonella phages and transient application in egg, meat and lettuce safety
    • Authors: Sun, X., Xue, F., Cong, C., Li, S., Xu, Y.
    • Journal: Food Research International
  • In vivo efficacy of phage cocktails against carbapenem resistance Acinetobacter baumannii in the rat pneumonia model
    • Authors: Li, S., Wei, B., Xu, L., Yin, J., Xu, Y.
    • Journal: Journal of Virology
  • Cold plasma: A success road to mycotoxins mitigation and food value edition
    • Authors: Murtaza, B., Wang, L., Li, X., Li, M., Xu, Y.
    • Journal: Food Chemistry
  • Toxicodynamic of combined mycotoxins: MicroRNAs and acute-phase proteins as diagnostic biomarkers
    • Authors: Murtaza, B., Li, X., Nawaz, M.Y., Wang, L., Xu, Y.
    • Journal: Comprehensive Reviews in Food Science and Food Safety